ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr | ₹4.03 Cr | ₹4.14 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4.52 Cr |
Mar2023 | ₹1.96 Cr |
Mar2022 | ₹1.63 Cr |
Mar2021 | ₹4.03 Cr |
Mar2020 | ₹4.14 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.52 Cr | 130.38 | |
Mar2023 | ₹1.96 Cr | 20.22 | |
Mar2022 | ₹1.63 Cr | -59.46 | |
Mar2021 | ₹4.03 Cr | -2.78 | |
Mar2020 | ₹4.14 Cr | - |
Compare Contingent Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹478.7 Cr | -1.7% | 4.1% | -35.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,686.0 Cr | 0.8% | -1.3% | 10.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,075.0 Cr | 1.5% | 2.3% | 47.2% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 0.9% | -3.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,971.0 Cr | -0.1% | 7.2% | 11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,121.0 Cr | -2.7% | -0.3% | 9.9% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | -1.7% |
4.1% |
-35.4% |
SENSEX | 0.1% |
1.2% |
6% |
You may also like the below Video Courses